MedQraft
← All insights
Regulatory pathways

Medical Device Authorization in Korea: Five Things to Define Before Searching for a Product Category

This article organizes the necessary product information before reviewing the pathway for medical device approval in Korea.
It details how to specify the scope of review based on intended use, mechanism of action, composition, conditions of use, and differences from existing products.

Last regulatory review: 2026-09-11 Rev. 1.1 4 min read

Reasons It Is Difficult to Determine Pathways Based on Similar Names Alone

When preparing for approval, the first step is often to find item names and classifications of similar products.

The search results are just a starting point; simply finding products with similar appearances or names does not determine the application pathway.

The MFDS approval procedure guidance includes not only targets for Class 3 and Class 4 approvals but also cases where Classes 1 and 2 are eligible for approval.

One should not conclude the approval, certification, or reporting pathway based solely on a single grade number.

MFDS Medical Device Approval Procedures

The five items below are MedQraft's product description structure for initial review rather than a legal submission format.

Five Aspects to Include in a One-Page Product Description

Item Content to Organize Expressions to Avoid
Intended Use What is being measured, diagnosed, treated, or assisted? ‘A device that helps health’
Mechanism of Action What inputs and operations lead to results? Listing only key component names
Product Composition Differences in hardware, accessories, consumables, software, and models Describing prototypes that differ from market composition
Conditions of Use User, subjects, location, and method ‘Anyone can use it anywhere’
Comparison Target and Differences Differences in purpose, principle, materials, and performance ‘Almost identical to existing products’

Unconfirmed information should be marked as 'under review'.

Particularly, the current range of products and future development scope should be separated to reduce the frequency of changing review targets.

The Description of Reviewed Products Differs Even with the Same Sensor

For instance, one hypothetical sensor product displays measurement values, while another interprets values to provide judgments concerning specific conditions.

This difference cannot be sufficiently explained by simply stating 'additional screen functionality'.

It is essential to explain who receives what information and how the user makes decisions based on it.

This example does not relate to determining specific ratings or whether a product qualifies as a medical device.

It is recommended that developers and regulatory affairs personnel review the same product together, placing the intended use statement next to the functionality list and results screens for collective examination.

Include Grounds for Judgment in Comparison Tables

When comparing with existing products, do not merely fill in identical and different columns, but also document what materials were checked.

Do not simply mark as 'identical' if the raw materials or test conditions are unknown.

Dividing each comparison item into verified information, remaining differences, and additional verification needs will illuminate unresolved issues.

Identifying what needs confirmation first can reduce commencing tests or documentation work without direction.

Create Submission Material Lists After Product Description

Using the test list of another product directly may result in omitted necessary assessments, or tests may be commissioned without reviewing their applicability.

Below is a list of questions to evaluate necessity rather than a final submission obligation list.

Product Characteristics Review Questions Initial Verification Materials
Human Contact Which parts are contacted, in what way, and how much? Contact material, structure, and usage conditions
Electrical Use What are the power and usage environment, and what devices are connected? Electrical schematic, usage environment, accessories list
Sterilization Supply How is the condition maintained through processing and packaging? Sterilization and packaging specifications and available evaluation materials
Software What inputs are processed, and how are results utilized? Function specification, version, result screen
Performance Claims What can be explained under which conditions? Specifications, test methods, available results

Each item in the table is a starting point for review.

This does not mean that the same tests are required for all products or that a single report can substitute for documentation.

The actual submission range and the applicability of exemptions must be confirmed based on applied regulations and individual product justifications.

Connect Initial Review Outcomes Back to Development Changes

Consider a hypothetical product where the material of a disposable accessory was changed during the review process.

Merely altering the drawings can cause discrepancies between the product description and the test materials.

Reflect any changes in the product description and reassess the impact on existing comparison and evaluation plans.

Internal review records should document what part changed from what to what, which models and timings apply, and what data validates the effects instead of just noting 'material change'.

If it is a previously approved product, it is also necessary to review whether the change procedures apply separately.

Summarize the Initial Review Results in Three Bundles

  1. Confirmed Items: Product composition and intended use, confirmed regulatory and item information, and sources.
  2. Unresolved Items: Questions needing additional materials or confirmations with relevant authorities, as well as assigned personnel.
  3. Follow-up Work: Determined tasks such as data research, evaluation planning, and technical document organization, along with prerequisites.

By organizing in this manner, one can transform the expression 'preparing for approval' into actionable tasks.

Even though the first review does not guarantee ratings, total costs, or timeline, subsequent steps can be concretely decided.

Materials to Prepare Before Consulting

Initially, a product description, composition diagram, operation video or screenshots, comparison target information, and a test materials list will be useful.

Additionally, include version numbers and date of creation.

The aim is to prevent mixing product descriptions from different points in time.

Later, review applicable regulations, item classifications, grades, application pathways, technical documents, and quality management tasks.

It is also necessary to check separate application systems for digital medical devices and in vitro diagnostic medical devices.

MedQraft currently confirms the state of product definitions and documents to negotiate the additional scope of approval and quality tasks.

Actual submission decisions must be based on current laws, announcements, and product characteristics.

Let's talk

Apply what you have read
to your product.

Tell us your product's current stage and the questions you need to review.

Discuss your questions ↗
MedQraft / Let's talk

Project inquiry

Start with your challenge.
We will work through it together.

Tell us your product's current stage and the support you need.
We will review the questions and define a suitable scope of support.

Contact@medqraft.co.kr ↗
Information: name, company, email, inquiry and service of interest · Purpose: responding to your inquiry · Retention: until the inquiry is resolved Read the privacy policy
Privacy policy

MedQraft / Privacy

Privacy policy

MedQraft processes only the information needed for website inquiries.
We delete the collected inquiry information when the inquiry is resolved.

Effective date: September 18, 2026

1. Scope and purposes of processing

This policy applies to visits and business inquiries at www.medqraft.co.kr.
We process personal information to review and respond to inquiries, discuss the scope of support, and operate the website reliably.
Customer business data stored in Q-Atelier is governed by the relevant service agreement and separate notices.

2. Information collected and retention

Required information
Name, email address and inquiry
Optional information
Company, selected service of interest, and contact or business details you provide in your inquiry
Collection methods
Website inquiry forms and email inquiries
Basis for processing
Consent to collection and use provided through the inquiry form.
Where necessary to fulfill a request relating to the formation or performance of a contract, we process information on the applicable legal basis.
Retention period
We retain inquiry information until the inquiry is resolved, then delete it without delay.
If information becomes part of a separate contract, we separately explain the required information and retention period.
Where retention is legally required, only the relevant information is stored separately.

You may decline to provide required information, but this will prevent submission of the website inquiry form.
You can make an inquiry without providing optional information.
Do not submit sensitive information unnecessary for the inquiry, such as national identification numbers or patient information.

3. Service providers and external services

Inquiries are forwarded from the website server through an email delivery service to our company mailbox.
We do not maintain a separate inquiry database in this processing workflow.

Vercel Inc.
Website hosting, server-side inquiry processing, operations and security.
Technical information such as IP address, request time, browser and request details may be processed.
Plus Five Five, Inc. (Resend)
Delivery of inquiry notification emails containing name, email, company, service of interest and inquiry details, and management of delivery logs
Gabia Hiworks
Receipt, storage and replies to inquiries in our company mailbox

We do not sell inquiry information or provide it for advertising purposes.
We do not disclose it for an independent third party's purposes unless there is a lawful basis, such as a legal requirement or separate consent.

4. Overseas processing and storage

Overseas cloud services are used to process website requests and deliver emails.
Information entered in an inquiry is transmitted over an encrypted connection upon submission.

Vercel Inc. / United States
Information is transmitted for inquiry request processing and hosting.
Privacy contact: privacy@vercel.com.
Operational records are subject to the retention periods of the services and settings used and Vercel's processing policies.
Vercel data processing information
Plus Five Five, Inc. (Resend) / United States
Information is transmitted upon submission to deliver the inquiry email and manage delivery records.
Privacy contact: privacy@resend.com.
Resend's published default retention period for emails and logs on its standard plans is 30 days.
Earlier deletion may be requested from the provider.
Resend retention and deletion information

Deleting inquiry emails from our mailbox and deleting technical records held by external providers involve different processes.
You may contact the person listed below about deletion, restriction of processing or overseas processing.
If you do not wish to use overseas processing through the website form, you may email us directly.
The processing policies of the email services used will still apply.

5. Deletion and safeguards

After confirming that an inquiry has been resolved, we delete the email and separately saved copies.
Printed materials, if any, are destroyed by shredding or another method that prevents reuse.
Where deletion of information held by an external processor is necessary, we submit a request through that provider's deletion procedure.

Access to personal information is restricted to staff who need it for their work.
We protect information through HTTPS transmission and account access controls.
We do not publish materials containing personal information in public repositories or on public pages.

6. Your rights

You may request access, correction, deletion, restriction of processing or withdrawal of consent by contacting the designated email address.
We will verify your identity to the extent necessary, process the request under applicable law, and notify you of the result.
If we cannot fulfill a request, for example because of a legal retention obligation, we will explain the reason.
For requests made through a representative, we may verify their authority.

7. Access information and external content

We use Naver conversion tracking to measure visits and completed inquiries attributable to Naver search advertising.
Technical information such as the visited URL, referring page, browser and cookies, and whether an inquiry was completed, may be processed.
The name, email, company and inquiry text entered in the form are not included in conversion events.
You can block or delete cookies in your browser.

Server access information may be processed for website delivery and security.
Vercel Web Analytics is used for anonymous visitor statistics on the introduction page and Insights.
Insights statistics aggregate article views, referral sources, countries and device types.
Visitor analytics do not use analytics cookies.
Names, emails, companies and inquiry text from the consultation form are not included in analytics events.
Instagram-specific links use UTM parameters to identify referral sources.
Loading external video or fonts on the website may transmit technical information, including IP address and browser details, to the relevant provider.

You can block or delete cookies and site data in your browser settings.
Some features or external content may be restricted depending on your settings.

8. Privacy officer and contact

Business
MedQraft / Representative: Byeonghwi Kim
Privacy officer and inquiry contact
Byeonghwi Kim
Email
Contact@medqraft.co.kr
Postal inquiries
Suite 222, 56 Geumto-ro 80beon-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea (Geumto-dong, Widen Tower)

For privacy-related complaints, you may contact the Personal Information Infringement Report Center or the Personal Information Dispute Mediation Committee for assistance.

9. Changes to this policy

Changes to processing purposes, information collected, retention periods or service providers will be published on this page with their effective date.

September 18, 2026: Website inquiry privacy policy first published

October 14, 2026: Added information on Insights visitor analytics and Instagram referral measurement